Worldwide Burkholderia Infections Therapeutic Market Overview Report

1
Burkholderia Infections - Pipeline Review, H2
2013
Published Date December 2013

Price Single User US 2000
Corporate User US 6000
2
New Market Research Report on Burkholderia
Infections - Pipeline Review, H2 2013 added to
ReportsnReports.com
The Report, ''Burkholderia Infections - Pipeline
Review, H2 2013'', provides an overview of the
indications therapeutic pipeline. This report
provides information on the therapeutic
development for Burkholderia Infections, complete
with latest updates, and special features on
late-stage and discontinued projects. It also
reviews key players involved in the therapeutic
development for Burkholderia Infections.
Burkholderia Infections - Pipeline Review, Half
Year is built using data and information sourced
from proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Researchers team. Scope- A
snapshot of the global therapeutic scenario for
Burkholderia Infections.- A review of the
Burkholderia Infections products under
development by companies and universities/research
institutes based on information derived from
company and industry-specific sources.- Coverage
of products based on various stages of
development ranging from discovery till
registration stages.- A feature on pipeline
projects on the basis of monotherapy and combined
therapeutics.- Coverage of the Burkholderia
Infections pipeline on the basis of route of
administration and molecule type.- Key
discontinued pipeline projects. Inquire for a
discount _at_ http//www.reportsnreports.com/contacts
/discount.aspx?name273670 .
3
New Market Research Report on Burkholderia
Infections - Pipeline Review, H2 2013 added to
ReportsnReports.com
Reasons to buy- Identify and understand
important and diverse types of therapeutics under
development for Burkholderia Infections. -
Identify emerging players with potentially strong
product portfolio and design effective
counter-strategies to gain competitive
advantage. - Plan mergers and acquisitions
effectively by identifying players of the most
promising pipeline. - Devise corrective measures
for pipeline projects by understanding
Burkholderia Infections pipeline depth and focus
of Indication therapeutics. - Develop and design
in-licensing and out-licensing strategies by
identifying prospective partners with the most
attractive projects to enhance and expand
business potential and scope. - Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline. Inquire for a discount _at_
http//www.reportsnreports.com/contacts/discount.a
spx?name273670 .
4
New Market Research Report on Burkholderia
Infections - Pipeline Review, H2 2013 added to
ReportsnReports.com
Table of Contents Table of Contents 2List of
Tables 4List of Figures 4Introduction 5Report
Coverage 5Burkholderia Infections Overview
6Therapeutics Development 7Pipeline Products
for Burkholderia Infections - Overview 7Pipeline
Products for Burkholderia Infections -
Comparative Analysis 8Burkholderia Infections -
Therapeutics under Development by Companies
9Burkholderia Infections - Therapeutics under
Investigation by Universities/Institutes
10Burkholderia Infections - Pipeline Products
Glance 11Early Stage Products 11Burkholderia
Infections - Products under Development by
Companies 12Burkholderia Infections - Products
under Investigation by Universities/Institutes
13 Inquire for a discount _at_ http//www.reportsn
reports.com/contacts/discount.aspx?name273670 .
5
New Market Research Report on Burkholderia
Infections - Pipeline Review, H2 2013 added to
ReportsnReports.com
Burkholderia Infections - Companies Involved in
Therapeutics Development 14Novabiotics Ltd
14Aridis Pharmaceuticals LLC 15NanoBio
Corporation 16iQur Ltd. 17Burkholderia
Infections - Therapeutics Assessment
18Assessment by Monotherapy Products
18Assessment by Target 19Assessment by
Mechanism of Action 21Assessment by Route of
Administration 23Assessment by Molecule Type
25Assessment by Therapeutic Class 27Drug
Profiles 29gallium citrate Ga 67 - Drug Profile
29Product Description 29Mechanism of Action
29RD Progress 29 Inquire for a discount _at_
http//www.reportsnreports.com/contacts/discount.a
spx?name273670 .
Table of Contents
6
New Market Research Report on Burkholderia
Infections - Pipeline Review, H2 2013 added to
ReportsnReports.com
Novarifyn - Drug Profile 30Product Description
30Mechanism of Action 30RD Progress 30NB-401
- Drug Profile 31Product Description
31Mechanism of Action 31RD Progress 31Drug
For Cystic Fibrosis - Drug Profile 32Product
Description 32Mechanism of Action 32RD
Progress 32Burkholderia Vaccine - Drug Profile
33Product Description 33Mechanism of Action
33RD Progress 33Subunit Vaccine For
Burkholderia Infections - Drug Profile 34
Inquire for a discount _at_ http//www.reportsnreport
s.com/contacts/discount.aspx?name273670 .
Table of Contents
7
About ReportsnReports
ReportsnReports.com is your single source for all
market research needs. Our database includes
250,000 syndicated market research reports from
100 leading global publishers covering in-depth
analysis of over 5000 micro markets. With
comprehensive information about the publishers
and their report methodology, data sources, etc.
we help you in your purchase decision by mapping
your information needs with the most relevant
available reports in our library. Connect with
us sales_at_reportsandreports.com 1 888 391 5441
Contact sales_at_reportsandreports.com for further
information.
Contact sales_at_reportsandreports.com for further
information.